Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

88,569 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lower mortality with andexanet alfa vs 4-factor prothrombin complex concentrate for factor Xa inhibitor-related major bleeding in a U.S. hospital-based observational study.
Dobesh PP, Fermann GJ, Christoph MJ, Koch B, Lesén E, Chen H, Lovelace B, Dettling T, Danese M, Ulloa J, Danese S, Coleman CI. Dobesh PP, et al. Among authors: chen h. Res Pract Thromb Haemost. 2023 Aug 30;7(6):102192. doi: 10.1016/j.rpth.2023.102192. eCollection 2023 Aug. Res Pract Thromb Haemost. 2023. PMID: 37753225 Free PMC article.
Early versus late intensification of glucose-lowering therapy in patients with type 2 diabetes: Results from the DISCOVER study.
Ji L, Bonnet F, Chen H, Cooper A, Hammar N, Leigh P, Luporini Saraiva G, Ramirez L, Medina J, Nicolucci A, Rathmann W, Shestakova MV, Surmont F, Tang F, Watada H; DISCOVER Investigators. Ji L, et al. Among authors: chen h. Diabetes Res Clin Pract. 2021 Aug;178:108947. doi: 10.1016/j.diabres.2021.108947. Epub 2021 Jul 10. Diabetes Res Clin Pract. 2021. PMID: 34252505
Health-related quality of life in patients with type 2 diabetes initiating a second-line glucose-lowering therapy: The DISCOVER study.
Nicolucci A, Chen H, Cid-Ruzafa J, Cooper A, Fenici P, Gomes MB, Hammar N, Khunti K, Kosiborod M, Leigh P, Medin J, Rathmann W, Shestakova MV, Shimomura I, Siddiqui A, Tang F, Watada H, Ji L; DISCOVER investigators. Nicolucci A, et al. Among authors: chen h. Diabetes Res Clin Pract. 2021 Oct;180:108974. doi: 10.1016/j.diabres.2021.108974. Epub 2021 Jul 22. Diabetes Res Clin Pract. 2021. PMID: 34302913
Socioeconomic factors associated with hypoglycaemia in patients starting second-line glucose-lowering therapy: The DISCOVER study.
Rathmann W, Charbonnel B, Gomes MB, Hammar N, Khunti K, Kosiborod M, Kuss O, Shestakova MV, Watada H, Shimomura I, Tang F, Cid-Ruzafa J, Chen H, Fenici P, Surmont F, Ji L; DISCOVER investigators. Rathmann W, et al. Among authors: chen h. Diabetes Res Clin Pract. 2020 Jul;165:108250. doi: 10.1016/j.diabres.2020.108250. Epub 2020 Jun 10. Diabetes Res Clin Pract. 2020. PMID: 32531326
Quality of life in people with type 2 diabetes in the 3 years following initiation of second-line therapy: The DISCOVER study.
Nicolucci A, Chen H, Cooper A, Fenici P, Gomes MB, Hammar N, Ji L, Khunti K, Kosiborod M, Medin J, Shestakova MV, Shimomura I, Tang F, Vora J, Watada H, Arnold SV; DISCOVER investigators. Nicolucci A, et al. Among authors: chen h. Diabetes Res Clin Pract. 2022 Mar;185:109218. doi: 10.1016/j.diabres.2022.109218. Epub 2022 Jan 31. Diabetes Res Clin Pract. 2022. PMID: 35114299
Contemporary outcomes of anemia in US patients with chronic kidney disease.
Wittbrodt ET, James G, Kumar S, van Haalen H, Chen H, Sloand JA, Kalantar-Zadeh K. Wittbrodt ET, et al. Among authors: chen h. Clin Kidney J. 2021 Oct 6;15(2):244-252. doi: 10.1093/ckj/sfab195. eCollection 2022 Feb. Clin Kidney J. 2021. PMID: 35145639 Free PMC article.
Prevalence of undiagnosed stage 3 chronic kidney disease in France, Germany, Italy, Japan and the USA: results from the multinational observational REVEAL-CKD study.
Tangri N, Moriyama T, Schneider MP, Virgitti JB, De Nicola L, Arnold M, Barone S, Peach E, Wittbrodt E, Chen H, Järbrink K, Kushner P. Tangri N, et al. Among authors: chen h. BMJ Open. 2023 May 22;13(5):e067386. doi: 10.1136/bmjopen-2022-067386. BMJ Open. 2023. PMID: 37217263 Free PMC article.
Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting.
Johannes CB, Beachler DC, Layton JB, Danysh HE, Ziemiecki R, Arana A, Dinh J, Li L, Calingaert B, Pladevall-Vila M, Hunt PR, Chen H, Karlsson C, Johnsson K, Gilsenan A. Johannes CB, et al. Among authors: chen h. Drug Saf. 2023 Feb;46(2):157-174. doi: 10.1007/s40264-022-01263-3. Epub 2022 Dec 17. Drug Saf. 2023. PMID: 36528670 Free PMC article.
88,569 results
You have reached the last available page of results. Please see the User Guide for more information.